首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report 2
【24h】

An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report 2

机译:价值的概述、角度和决定背景卫生经济学的方法:一个ISPOR特别工作组报道2

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The second section of our Special Task Force builds on the discussion of value and perspective in the previous article of the report by 1) defining a health economics approach to the concept of value in health care systems; 2) discussing the relationship of value to perspective and decision context, that is, how recently proposed value frameworks vary by the types of decisions being made and by the stakeholders involved; 3) describing the patient perspective on value because the patient is a key stakeholder, but one also wearing the hat of a health insurance purchaser; and 4) discussing how value is relevant in the market-based US system of mixed private and public insurance, and differs from its use in single-payer systems. The five recent value frameworks that motivated this report vary in the types of decisions they intend to inform, ranging from coverage, access, and pricing decisions to those defining appropriate clinical pathways and to supporting provider-clinician shared decision making. Each of these value frameworks must be evaluated in its own decision context for its own objectives. Existing guidelines for cost-effectiveness analysis emphasize the importance of clearly specifying the perspective from which the analysis is undertaken. Relevant perspectives may include, among others, 1) the health plan enrollee, 2) the patient, 3) the health plan manager, 4) the provider, 5) the technology manufacturer, 6) the specialty society, 7) government regulators, or 8) society as a whole. A valid and informative cost-effectiveness analysis could be conducted from the perspective of any of these stakeholders, depending on the decision context.
机译:第二部分我们的特别工作组基于价值的讨论和观点在前一篇文章中报告的1)定义一个卫生经济学的方法价值的概念在卫生保健系统;讨论价值之间的关系角度和决策环境,如何做最近提议框架不同的值和类型的决策利益相关者的参与;对价值的看法,因为病人是一个关键利益相关者,但一个也戴的帽子健康保险购买者;值是有关在美国市场系统混合的私人和公共保险,不同于单一支付系统的使用。最近五个价值框架动力他们打算报告不同的类型决定通知,从覆盖率、访问和定义适当的定价决策临床路径和支持provider-clinician共享决策。这些价值框架必须被评估自己的上下文决定自己的目标。现有指南成本效益分析强调明显的重要性指定的角度分析。包括,1)健康计划入会者,2),3)健康计划经理,4)提供者,5)技术制造商,6)专业的社会,7)政府监管机构、或社会作为一个整体。一个有效的和翔实的成本效益可以从角度进行分析这些利益相关者,这取决于上下文决定。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号